Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
protein that binds to Igf-I and Igf-II. Additionally we are shipping IGFBP2 Kits (83) and and many more products for this protein.
Showing 10 out of 116 products:
Human Monoclonal IGFBP2 Primary Antibody for EIA, IHC (p) - ABIN1107680
Miyake, Hara, Yamanaka, Muramaki, Gleave, Eto: Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential. in Oncology reports 2005
Show all 2 references for ABIN1107680
Human Polyclonal IGFBP2 Primary Antibody for EIA, WB - ABIN453697
Arafat, Weickert, Frystyk, Spranger, Schöfl, Möhlig, Pfeiffer: The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity. in The Journal of clinical endocrinology and metabolism 2009
Show all 2 references for ABIN453697
Human Monoclonal IGFBP2 Primary Antibody for IHC, ELISA - ABIN1724698
Fisher, Meyer, Garber, Dealy: Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth. in Bone 2005
Show all 2 references for ABIN1724698
Human Polyclonal IGFBP2 Primary Antibody for WB - ABIN2785659
Hertel, Johansson, Raeder, Midthjell, Lyssenko, Groop, Molven, Njølstad: Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study). in Diabetologia 2008
Data (including data from studies in knockout mice) suggest, as osteoblasts differentiate, early induction of AMPK (show PRKAA1 Antibodies) in response to IGF-I (show IGF1 Antibodies)/IGFBP-2 is followed by suppression of AMPK (show PRKAA1 Antibodies) as required for osteogenesis; activation of AMPK (show PRKAA1 Antibodies) stimulates autophagy.
estrogen deficiency has a profound effect on body and bone composition in the absence of IGFBP-2 and may be related to changes in fibroblast growth factor 21 (show FGF21 Antibodies).
Impaired glucose clearance in female IGFBP-2 transgenic mice is dependent on the presence of the RGD motif and that translocation of GLUT4 (show SLC2A4 Antibodies) in the muscle may be regulated by IGFBP-2 via RGD-dependent mechanisms.
protein(s) that associated with RPTPbeta (show PTPRZ1 Antibodies) in response to IGF-I (show IGF1 Antibodies) and IGFBP-2 in vascular smooth muscle cells
The results suggest that stimulation of differentiation is an important mechanism by which IGFBP-2 regulates the acquisition of normal bone mass in mice.
PPARalpha (show PPARA Antibodies) controls IGF-1 (show IGF1 Antibodies) signalling through the up-regulation of hepatic Igfbp-2 transcription during fasting.
IGFBP2 is a critical cell-autonomous factor that promotes the survival and migration of acute leukemia cells.
IGFBP-2 plays an IGF-I (show IGF1 Antibodies)-dependent and -independent role in the brain's acute (neuroprotection) and chronic (tissue remodeling) response to hypoxic-ischemic injury.
physiological levels of IGFBP2 are neither sufficient to mimic nor required for the physiological action of leptin (show LEP Antibodies)
Igfbp2-5 are expressed in distinct and complementary patterns during cochlear development.
There was a positive correlation between the IGFBP2 levels of and those of inflammatory mediators in HIV Infections.
IGFBP-2 overexpression in HUVECs promoted endothelial progenitor cells(EPC (show TCF21 Antibodies))-endothelial adhesion. The RGD motif in its C-domain is required for interaction with integrin alpha5beta1.
Serum IGFBP2 reflects disease activity and renal pathology changes in lupus nephritis.
Data show that modulation of insulin like growth factor binding protein 2 (IGFBP2) expression affects proliferation, motility, and chemosensitization of eophageal adenocarcinoma (EAC (show CYLD Antibodies)) cells in a serum-dependent manner.
Identification of a novel tumor-promoting function for IGFBP2 of activating EGFR (show EGFR Antibodies)/STAT3 (show STAT3 Antibodies) signaling and facilitating EGFR (show EGFR Antibodies) accumulation in the nucleus, thereby deregulating EGFR (show EGFR Antibodies) signaling by two distinct mechanisms.
that age-specific cognitive decline may be moderated by IGF-BP2
Serum IGFBP2 was increased in patients with hepatocellular carcinoma compared to healthy controls, but lower than in patients with liver cirrhosis.
The expression levels of maspin (show SERPINB5 Antibodies) were lower in the cisplatin-resistant tissue and cells, and was enhanced by IGFBP-2 inhibition.
Insulin-like growth factor binding protein 2 is strongly associated with restoration of keratocyte phenotype in HCFs.
Elevated serum IGFBP2 levels might play a role in the postnatal growth retardation phenotype of Pallister-Killian syndrome.
Results suggest that IGFBP-2 is associated with production performance in pigs.
Five novel SNPs were identified in IGFBP2, two of which had significant associations with fertility (age at conception in heifers and commencement of luteal activity) and 305-day milk yield in lactation 1.
The present study suggests that the insulin (show INS Antibodies) like growth factor (IGF) system or imbalances between IGF and IGF binding (show HTRA1 Antibodies) proteins may be involved in cystic ovary disease of cattle.
in preovulatory follicles, PAPP-A (show PAPPA Antibodies) is responsible for IGF-dependent IGFBP-2 degradation
spatial and temporal patterns of expression of IGFBP-2 and -3 were markedly altered in the placentomes of nuclear transfer pregnancies
protein that binds to Igf-I and Igf-II
insulin-like growth factor binding protein 2, 36kDa
, IGF-binding protein 2
, insulin-like growth factor-binding protein 2
, IGF binding protein 2
, insulin-like growth factor-binding protein-2, IGFBP-2